DCVC
Kiersten Stead is a highly experienced individual currently serving as a Board Member in various companies such as Mycoworks, Creyon Bio, Novome Biotechnologies, Elo Life Systems, Stemson Therapeutics, Sabanto, X-37, and DCVC Bio where Kiersten holds the position of Managing Partner. Kiersten also serves as a board member at Keystone Symposia on Molecular & Cellular Biology. Kiersten holds an MBA with a specialization in Finance, a Ph.D. in Molecular Biology and Genetics, and a B.Sc. in Cellular, Molecular and Microbial Biology from the University of Alberta and University of Calgary.
DCVC
1 followers
DCVC (Data Collective) and its principals have backed brilliant people changing global-scale industries for over twenty years, helping create tens of billions of dollars of wealth for these entrepreneurs while also making the world a markedly better place. DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 35 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford and Berkeley) with significant tenures at top 100 technology companies and research institutions worldwide. DCVC focuses on seed, Series A, and growth stage companies that apply deep compute, big data and IT infrastructure technologies to transform giant industries.